Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH 45237, NDC 00591-0900-30
Published August 24, 2016 · Recall initiated: June 30, 2016
Summary
FDA records drug Class II recall D-1457-2016, published August 24, 2016 and initiated June 30, 2016. Recalling firm: Actavis Inc; Status: Terminated; Reported quantity: 167,152 bottles; Lot: Lot # 3132593, 3132594, 3134420, 3134421,3134422, Exp. 02/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Actavis Inc
- Distributor
- Nationwide
- Lot
- Lot # 3132593, 3132594, 3134420, 3134421,3134422, Exp. 02/17
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevofloxacin Ophthalmic Solution, 0.5%, Sterile, packaged in 5mL bottles, Rx Only, Manufactured by Hi-TechMarch 15, 2017
- FDAGlipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon PharmaceuticalsFebruary 22, 2017
- FDAAlbuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for WatsonFebruary 1, 2017
- FDAAcetasol HC (hydrocortisone and acetic acid otic solution USP) , Rx Only, 10 mL bottle, Manufactured by:August 31, 2016
- FDAVenlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules per bottle, NDC # 60429-123-30, b)August 24, 2016
- FDAMedicine Cup, 1 OZ. Liquid medication dispenser to issue a measured amount of liquid medication.August 17, 2016
Questions about this recall
Was Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH 45237, NDC 00591-0900-30 recalled?
Yes. FDA published recall D-1457-2016 on August 24, 2016. Reported hazard: Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.
What should I do if I have this product?
Voluntary: Firm initiated · Letter